These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22332914)

  • 21. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
    Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
    Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient characteristics correlated with quality indicator outcomes in diabetes care.
    Shani M; Nakar S; Lustman A; Baievsky T; Rosenberg R; Vinker S
    Br J Gen Pract; 2010 Sep; 60(578):655-9. PubMed ID: 20849693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
    Ahmad Khan H
    Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change.
    Grant RW; Buse JB; Meigs JB;
    Diabetes Care; 2005 Feb; 28(2):337-442. PubMed ID: 15677789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study.
    Huppertz E; Pieper L; Klotsche J; Stridde E; Pittrow D; Böhler S; Lehnert H
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):6-14. PubMed ID: 18465681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.
    Khan HA; Sobki SH; Khan SA
    Clin Exp Med; 2007 Mar; 7(1):24-9. PubMed ID: 17380302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
    Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
    BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT; Smith HT; Hards M; Curtis BH; Ivanyi T
    Diabet Med; 2012 Jul; 29(7):e13-20. PubMed ID: 22268988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indirect effects of decompression surgery on glycemic homeostasis in patients with type 2 diabetes mellitus and lumbar spinal stenosis.
    Kim HJ; Lee KW; Cho HG; Kang KT; Chang BS; Lee CK; Yeom JS
    Spine J; 2015 Jan; 15(1):25-33. PubMed ID: 24983668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased peripheral blood mitochondrial DNA content is related to HbA1c, fasting plasma glucose level and age of onset in type 2 diabetes mellitus.
    Xu FX; Zhou X; Shen F; Pang R; Liu SM
    Diabet Med; 2012 Jul; 29(7):e47-54. PubMed ID: 22211946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
    Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
    Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous low- to moderate-intensity exercise training is as effective as moderate- to high-intensity exercise training at lowering blood HbA(1c) in obese type 2 diabetes patients.
    Hansen D; Dendale P; Jonkers RA; Beelen M; Manders RJ; Corluy L; Mullens A; Berger J; Meeusen R; van Loon LJ
    Diabetologia; 2009 Sep; 52(9):1789-97. PubMed ID: 19370339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
    Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006?
    Cosson E; Nguyen MT; Hamo-Tchatchouang E; Banu I; Chiheb S; Charnaux N; Valensi P
    Diabet Med; 2011 May; 28(5):567-74. PubMed ID: 21480967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial.
    Young RJ; Taylor J; Friede T; Hollis S; Mason JM; Lee P; Burns E; Long AF; Gambling T; New JP; Gibson JM
    Diabetes Care; 2005 Feb; 28(2):278-82. PubMed ID: 15677779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of blood glucose and HbA(1c) goals on glycaemic control in children and adolescents with Type 1 diabetes.
    Boot M; Volkening LK; Butler DA; Laffel LM
    Diabet Med; 2013 Mar; 30(3):333-7. PubMed ID: 23190135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Earlier triple therapy with pioglitazone in patients with type 2 diabetes.
    Charpentier G; Halimi S;
    Diabetes Obes Metab; 2009 Sep; 11(9):844-54. PubMed ID: 19614944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.